NETs present in TME have the ability to form a physical barrier that prevents immune effector cells: NK cells (Natural Killer), CD8+ T lymphocytes, cytotoxic T lymphocytes (CTL) from coming into contact with tumor cells, thereby mitigating their anti-tumor effects, primarily the elimination of tumor cells (10, 11). The gene discussed is TNFRSF10B; the disease is neoplasm.